To the best of our knowledge, this is the first study to evaluate whether vitamin E supplementation suppresses the development of NAFLD by elevating CPT‐1 protein levels in the liver although the details are uncertain. Here, CPT1A is linked to metabolic dysfunction-associated steatotic liver disease.